Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00052572
First received: January 24, 2003
Last updated: June 21, 2013
Last verified: April 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given